NSE - Delayed Quote INR

Tatva Chintan Pharma Chem Limited (TATVA.NS)

903.10
-16.25
(-1.77%)
At close: May 30 at 3:30:01 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
3,827,140
3,827,140
3,935,040
4,208,910
4,312,930
Cost of Revenue
1,989,410
1,989,410
1,741,820
2,345,910
2,076,780
Gross Profit
1,837,730
1,837,730
2,193,220
1,863,000
2,236,150
Operating Expense
1,772,190
1,772,190
1,767,310
1,275,650
1,228,100
Operating Income
65,540
65,540
425,910
587,350
1,008,050
Net Non Operating Interest Income Expense
-12,900
-12,900
-65,320
-32,660
-5,650
Pretax Income
75,790
75,790
435,680
447,790
1,041,210
Tax Provision
18,660
18,660
132,140
-7,080
82,470
Net Income Common Stockholders
57,130
57,130
303,540
454,870
958,740
Diluted NI Available to Com Stockholders
57,130
57,130
303,540
454,870
958,740
Basic EPS
2.44
--
13.26
20.52
44.59
Diluted EPS
2.44
--
13.26
20.52
44.59
Basic Average Shares
23,413.93
--
22,891.40
22,165.06
21,499.10
Diluted Average Shares
23,413.93
--
22,891.40
22,165.06
21,499.10
Rent Expense Supplemental
--
--
15,440
18,780
11,400
Total Expenses
3,761,600
3,761,600
3,509,130
3,621,560
3,304,880
Net Income from Continuing & Discontinued Operation
57,130
57,130
303,540
454,870
958,740
Normalized Income
57,130
57,130
303,540
481,246
959,596.34
Interest Income
--
--
32,840
53,340
46,680
Interest Expense
12,900
12,900
65,320
79,970
43,510
Net Interest Income
-12,900
-12,900
-65,320
-32,660
-5,650
EBIT
88,690
88,690
501,000
527,760
1,084,720
EBITDA
365,280
365,280
757,050
623,310
1,166,520
Reconciled Cost of Revenue
1,989,410
1,989,410
1,741,820
2,345,910
2,076,780
Reconciled Depreciation
276,590
276,590
256,050
95,550
81,800
Net Income from Continuing Operation Net Minority Interest
57,130
57,130
303,540
454,870
958,740
Total Unusual Items Excluding Goodwill
0
0
0
-37,680
-930
Total Unusual Items
0
0
0
-37,680
-930
Normalized EBITDA
365,280
365,280
757,050
660,990
1,167,450
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-11,304
-73.66
3/31/2022 - 7/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NEOGEN.NS Neogen Chemicals Limited
1,680.20
+1.57%
 
OAL.NS Oriental Aromatics Limited
361.60
-2.14%
 
KIRIINDUS.NS Kiri Industries Limited
642.05
-11.63%
 
GALAXYSURF.NS Galaxy Surfactants Limited
2,306.10
+0.83%
 
ANURAS.NS Anupam Rasayan India Ltd
1,004.75
+1.52%
 
TAINWALCHM.NS Tainwala Chemicals and Plastics (India) Limited
207.62
-0.54%
 
CAPRIHANS.BO Caprihans India Limited
133.20
+0.34%
 
GUJPETR.BO Gujarat Petrosynthese Limited
62.53
-3.20%
 
ASAHISONG.NS Asahi Songwon Colors Limited
421.90
-2.48%
 
JUBLCPL.NS Jubilant Agri and Consumer Products Limited
1,561.70
-3.48%